In U251MG cells and the primary human glioma cells (“P1/P2”), “Transwell” and “Matrigel Transwell” assay results show that Ninj2 shRNA significantly decreased the number of migrated (Figure 4C) and invasive (Figure 4D) glioma cells. Here, NINJ2 is linked to central nervous system cancer.